2013 Q3 Form 10-Q Financial Statement
#000110465913055542 Filed on July 22, 2013
Income Statement
| Concept | 2013 Q3 |
|---|---|
| Revenue | $0.00 |
| YoY Change | |
| Cost Of Revenue | |
| YoY Change | |
| Gross Profit | |
| YoY Change | |
| Gross Profit Margin | |
| Selling, General & Admin | $2.480M |
| YoY Change | -17.33% |
| % of Gross Profit | |
| Research & Development | $6.477M |
| YoY Change | -33.66% |
| % of Gross Profit | |
| Depreciation & Amortization | $70.00K |
| YoY Change | -63.16% |
| % of Gross Profit | |
| Operating Expenses | $8.960M |
| YoY Change | -29.8% |
| Operating Profit | -$8.960M |
| YoY Change | -29.8% |
| Interest Expense | |
| YoY Change | |
| % of Operating Profit | |
| Other Income/Expense, Net | $23.00K |
| YoY Change | -148.94% |
| Pretax Income | -$8.937M |
| YoY Change | -30.23% |
| Income Tax | $0.00 |
| % Of Pretax Income | |
| Net Earnings | -$8.937M |
| YoY Change | -275.2% |
| Net Earnings / Revenue | |
| Basic Earnings Per Share | |
| Diluted Earnings Per Share | -$1.415M |
| COMMON SHARES | |
| Basic Shares Outstanding | 63.19M shares |
| Diluted Shares Outstanding |
Balance Sheet
| Concept | 2013 Q3 |
|---|---|
| SHORT-TERM ASSETS | |
| Cash & Short-Term Investments | $21.00M |
| YoY Change | -55.6% |
| Cash & Equivalents | $19.28M |
| Short-Term Investments | $1.700M |
| Other Short-Term Assets | $800.0K |
| YoY Change | -33.33% |
| Inventory | |
| Prepaid Expenses | |
| Receivables | |
| Other Receivables | |
| Total Short-Term Assets | $21.79M |
| YoY Change | -69.44% |
| LONG-TERM ASSETS | |
| Property, Plant & Equipment | $217.0K |
| YoY Change | -63.83% |
| Goodwill | |
| YoY Change | |
| Intangibles | |
| YoY Change | |
| Long-Term Investments | |
| YoY Change | |
| Other Assets | |
| YoY Change | |
| Total Long-Term Assets | $704.0K |
| YoY Change | -21.78% |
| TOTAL ASSETS | |
| Total Short-Term Assets | $21.79M |
| Total Long-Term Assets | $704.0K |
| Total Assets | $22.49M |
| YoY Change | -68.85% |
| SHORT-TERM LIABILITIES | |
| YoY Change | |
| Accounts Payable | $1.253M |
| YoY Change | 4.42% |
| Accrued Expenses | $3.900M |
| YoY Change | -62.14% |
| Deferred Revenue | |
| YoY Change | |
| Short-Term Debt | $0.00 |
| YoY Change | |
| Long-Term Debt Due | |
| YoY Change | |
| Total Short-Term Liabilities | $5.165M |
| YoY Change | -55.09% |
| LONG-TERM LIABILITIES | |
| Long-Term Debt | $0.00 |
| YoY Change | |
| Other Long-Term Liabilities | $389.0K |
| YoY Change | -51.38% |
| Total Long-Term Liabilities | $389.0K |
| YoY Change | -51.38% |
| TOTAL LIABILITIES | |
| Total Short-Term Liabilities | $5.165M |
| Total Long-Term Liabilities | $389.0K |
| Total Liabilities | $5.554M |
| YoY Change | -54.85% |
| SHAREHOLDERS EQUITY | |
| Retained Earnings | -$447.6M |
| YoY Change | |
| Common Stock | $464.5M |
| YoY Change | |
| Preferred Stock | |
| YoY Change | |
| Treasury Stock (at cost) | |
| YoY Change | |
| Treasury Stock Shares | |
| Shareholders Equity | $16.94M |
| YoY Change | |
| Total Liabilities & Shareholders Equity | $22.49M |
| YoY Change | -68.85% |
Cashflow Statement
| Concept | 2013 Q3 |
|---|---|
| OPERATING ACTIVITIES | |
| Net Income | -$8.937M |
| YoY Change | -275.2% |
| Depreciation, Depletion And Amortization | $70.00K |
| YoY Change | -63.16% |
| Cash From Operating Activities | -$11.04M |
| YoY Change | 28.37% |
| INVESTING ACTIVITIES | |
| Capital Expenditures | $0.00 |
| YoY Change | -100.0% |
| Acquisitions | |
| YoY Change | |
| Other Investing Activities | $1.710M |
| YoY Change | 3320.0% |
| Cash From Investing Activities | $1.720M |
| YoY Change | 8500.0% |
| FINANCING ACTIVITIES | |
| Cash Dividend Paid | |
| YoY Change | |
| Common Stock Issuance & Retirement, Net | |
| YoY Change | |
| Debt Paid & Issued, Net | |
| YoY Change | |
| Cash From Financing Activities | 350.0K |
| YoY Change | |
| NET CHANGE | |
| Cash From Operating Activities | -11.04M |
| Cash From Investing Activities | 1.720M |
| Cash From Financing Activities | 350.0K |
| Net Change In Cash | -8.970M |
| YoY Change | 4.55% |
| FREE CASH FLOW | |
| Cash From Operating Activities | -$11.04M |
| Capital Expenditures | $0.00 |
| Free Cash Flow | -$11.04M |
| YoY Change | 28.97% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| dei |
Entity Registrant Name
EntityRegistrantName
|
GTX INC /DE/ | ||
| dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001260990 | ||
| dei |
Document Type
DocumentType
|
10-Q | ||
| dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
| dei |
Amendment Flag
AmendmentFlag
|
false | ||
| dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | ||
| dei |
Entity Filer Category
EntityFilerCategory
|
Accelerated Filer | ||
| dei |
Document Period End Date
DocumentPeriodEndDate
|
2013-06-30 | ||
| dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2013 | ||
| CY2013Q3 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
63185389 | shares |
| dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q2 | ||
| CY2012Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
0 | USD |
| CY2013Q2 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
0 | USD |
| CY2013Q2 | gtxi |
Accrual For Product Returns
AccrualForProductReturns
|
1045000 | USD |
| CY2012Q4 | gtxi |
Accrual For Product Returns
AccrualForProductReturns
|
1189000 | USD |
| CY2013Q2 | gtxi |
Accrual For Product Returns Included In Other Long Term Liabilities
AccrualForProductReturnsIncludedInOtherLongTermLiabilities
|
332000 | USD |
| CY2012Q4 | gtxi |
Accrual For Product Returns Included In Other Long Term Liabilities
AccrualForProductReturnsIncludedInOtherLongTermLiabilities
|
370000 | USD |
| CY2012Q2 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
286000 | USD |
| us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><b><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">Use of Estimates</font></i></b></p> <p style="MARGIN: 0in 0in 0pt;"> </p> <p style="TEXT-INDENT: 0.2in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">The preparation of condensed financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the condensed financial statements, and the reported amounts of revenues and expenses during the reporting period.  Actual amounts and results could differ from those estimates.</font></p> </div> | ||
| us-gaap |
Revenue Recognition Sales Of Goods
RevenueRecognitionSalesOfGoods
|
<div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><b><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">FARESTON</font></i></b><font style="POSITION: relative; FONT-SIZE: 6.5pt; TOP: -3pt;" size="1">®</font><b><i><font style="FONT-STYLE: italic; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2"> Revenue Recognition</font></i></b></p> <p style="MARGIN: 0in 0in 0pt;"> </p> <p style="TEXT-INDENT: 13.7pt; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Revenue from product sales of FARESTON</font><font style="POSITION: relative; FONT-SIZE: 6.5pt; TOP: -3pt;" size="1">®</font> <font style="FONT-SIZE: 10pt;" size="2">for the three and six months ended June 30, 2012, which was included in income from discontinued operations before income taxes, was recognized less deductions for estimated sales discounts and sales returns.  Revenue from product sales was recognized when persuasive evidence of an arrangement existed, title passed, the price was fixed or determinable, and collectability was reasonably assured.  The Company accounted for rebates to certain governmental agencies as a reduction of product sales.  The Company allows customers to return product within a specified time period prior to and subsequent to the product’s labeled expiration date.  Although the Company sold its rights and certain assets related to FARESTON</font><font style="POSITION: relative; FONT-SIZE: 6.5pt; TOP: -3pt;" size="1">®</font><font style="FONT-SIZE: 10pt;" size="2"> effective September 30, 2012, the Company retained the liability for future product returns relating to sales of FARESTON</font><font style="POSITION: relative; FONT-SIZE: 6.5pt; TOP: -3pt;" size="1">®</font><font style="FONT-SIZE: 10pt;" size="2"> made by the Company prior to September 30, 2012.  Therefore, the Company estimates an accrual for product returns based on factors which include historical product returns and estimated product in the distribution channel which is expected to exceed its expiration date.  At June 30, 2013 and December 31, 2012, the Company’s accrual for product returns, was $1,045 and $1,189, respectively.   Of these amounts, $332 and $370 have been included in “Other long-term liabilities” in the condensed balance sheet at June 30, 2013 and December 31, 2012, respectively, and represents the portion of the Company’s product returns accrual estimated to be payable after one year.  See Note 4, <i>Discontinued Operations</i>, for further discussion.</font></p> </div> | ||
| us-gaap |
Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
|
<div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><b><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">Reclassification</font></i></b></p> <p style="MARGIN: 0in 0in 0pt;"> </p> <p style="TEXT-INDENT: 13.7pt; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Certain prior period results have been reclassified to conform to the current period presentation.</font></p> </div> | ||
| CY2013Q2 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
714000 | USD |
| us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
1570000 | USD | |
| us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
1213000 | USD | |
| CY2013Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.757 | pure |
| CY2012Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.750 | pure |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.745 | pure | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.695 | pure | |
| CY2013Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.010 | pure |
| CY2012Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.013 | pure |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.011 | pure | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.012 | pure | |
| CY2013Q2 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P6Y | |
| CY2012Q2 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P6Y | |
| us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P6Y6M | ||
| us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P6Y6M | ||
| CY2012Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
5382859 | shares |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
|
1456700 | shares | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
|
258818 | shares | |
| us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
246339 | shares | |
| CY2013Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
6334402 | shares |
| CY2012Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
7.96 | |
| us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
4.24 | ||
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
|
9.00 | ||
| us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
3.53 | ||
| CY2013Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
7.24 | |
| CY2013Q2 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
6488055 | shares |
| CY2012Q2 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
5580340 | shares |
| us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
6583708 | shares | |
| us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
5756748 | shares |
